Debt-to-equity of Organogenesis Holdings Inc. from 30 Sep 2017 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Organogenesis Holdings Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2017 to 31 Dec 2025.
  • Organogenesis Holdings Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 47%, a 20% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Organogenesis Holdings Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 47% -12% -20% 31 Dec 2025
Q3 2025 44% -21% -32% 30 Sep 2025
Q2 2025 47% -19% -29% 30 Jun 2025
Q1 2025 53% -12% -19% 31 Mar 2025
Q4 2024 59% -7.7% -11% 31 Dec 2024
Q3 2024 65% -3.3% -4.8% 30 Sep 2024
Q2 2024 66% -4.3% -6.1% 30 Jun 2024
Q1 2024 66% -8.2% -11% 31 Mar 2024
Q4 2023 67% -10% -13% 31 Dec 2023
Q3 2023 68% -13% -16% 30 Sep 2023
Q2 2023 71% -14% -16% 30 Jun 2023
Q1 2023 74% -15% -17% 31 Mar 2023
Q4 2022 77% -18% -19% 31 Dec 2022
Q3 2022 80% -21% -21% 30 Sep 2022
Q2 2022 84% -42% -33% 30 Jun 2022
Q1 2022 89% -84% -49% 31 Mar 2022
Q4 2021 95% -151% -61% 31 Dec 2021
Q3 2021 101% -273% -73% 30 Sep 2021
Q2 2021 126% -368% -74% 30 Jun 2021
Q1 2021 173% -325% -65% 31 Mar 2021
Q4 2020 246% -264% -52% 31 Dec 2020
Q3 2020 375% -148% -28% 30 Sep 2020
Q2 2020 493% -92% -16% 30 Jun 2020
Q1 2020 499% +3761% 31 Mar 2020
Q4 2019 511% +716% 31 Dec 2019
Q3 2019 523% +674% 30 Sep 2019
Q2 2019 586% +780% 30 Jun 2019
Q1 2019 -3262% -2800% -606% 31 Mar 2019
Q4 2018 -206% +60602% +100% 31 Dec 2018
Q3 2018 -151% +4629% +97% 30 Sep 2018
Q2 2018 -194% 30 Jun 2018
Q1 2018 -462% 31 Mar 2018
Q4 2017 -60808% 31 Dec 2017
Q3 2017 -4781% 30 Sep 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.